Objective. To investigate whether use of adalimumab decreases the frequency of attacks of
anterior uveitis (AU) in patients with ankylosing spondylitis (AS). Methods. Consecutive …

Ann Rheum Dis May 2011 Vol 70 No 5 876 patients with PsA and the general population.
Owing to the response rate of 65%, the CV prevalence in PsA might be overestimated as …

Background Effective anti-inflammatory treatment with tumour necrosis factor α (TNFα) inhibitors
may have favourable effects on the lipid profile. Available evidence is derived from short-…

Objective To assess gender differences in body composition (BC) in a cohort of AS patients
naïve to TNF-α blockers. Methods Patients included fulfilled the Modified New York criteria …

Objective. Our main objective was to assess the relationship between body composition (BC)
and response to tumor necrosis factor-α (TNF-α) blocker treatment in patients with …

Objective C-reactive protein (CRP) levels are frequently used to determine disease activity
in patients with ankylosing spondylitis (AS), but these levels may not reflect disease activity. …

Rheumatoid arthritis (RA) is associated with higher risk for cardiovascular disease (CVD) in
comparison with the general population. 1 Traditional cardiovascular (CV) risk factors only …

Objective To study changes in retention of first biologic disease-modifying antirheumatic
drug (DMARD) therapy over a period of 15 years in an inception cohort of patients with …

3 Boekel L, Steenhuis M, Hooijberg F, et al. Antibody development after COVID-19 vaccination
in patients with autoimmune diseases in the Netherlands: a substudy of data from two …

… ; GJ Wolbink has received payment from Pfizer and Abbvie for consultancies, and grants/research
support from Pfizer; MJ l’Ami and IM Visman have declared no competing interests. …